Cite
MLA Citation
Kyle Singleton et al.. “NIMG-06. KINETICS-BASED RESPONSE METRIC DISCRIMINATE IMPROVED OUTCOMES FOR PATIENTS RECEIVING BEVACIZUMAB-BASED THERAPIES.” Neuro-oncology, vol. 20, n.d., pp. vi176–vi177. http://access.bl.uk/ark:/81055/vdc_100095520394.0x000012